Does ACALABRUTINIB Cause Nephrolithiasis? 73 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 73 reports of Nephrolithiasis have been filed in association with ACALABRUTINIB (CALQUENCE). This represents 0.8% of all adverse event reports for ACALABRUTINIB.
73
Reports of Nephrolithiasis with ACALABRUTINIB
0.8%
of all ACALABRUTINIB reports
2
Deaths
25
Hospitalizations
How Dangerous Is Nephrolithiasis From ACALABRUTINIB?
Of the 73 reports, 2 (2.7%) resulted in death, 25 (34.2%) required hospitalization, and 1 (1.4%) were considered life-threatening.
Is Nephrolithiasis Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for ACALABRUTINIB. However, 73 reports have been filed with the FAERS database.
What Other Side Effects Does ACALABRUTINIB Cause?
Death (1,857)
Fatigue (536)
Headache (534)
Product dose omission issue (349)
Diarrhoea (320)
Fall (289)
Malignant neoplasm progression (285)
Contusion (270)
Dyspnoea (259)
Pneumonia (244)
What Other Drugs Cause Nephrolithiasis?
ADALIMUMAB (2,416)
ETANERCEPT (1,292)
INFLIXIMAB (981)
METHOTREXATE (979)
ABATACEPT (788)
TOPIRAMATE (768)
CERTOLIZUMAB PEGOL (735)
RITUXIMAB (709)
TOFACITINIB (699)
SODIUM OXYBATE (698)
Which ACALABRUTINIB Alternatives Have Lower Nephrolithiasis Risk?
ACALABRUTINIB vs ACAMPROSATE
ACALABRUTINIB vs ACARBOSE
ACALABRUTINIB vs ACCUTANE
ACALABRUTINIB vs ACEBUTOLOL
ACALABRUTINIB vs ACECLOFENAC